fluorodeoxyglucose f18 has been researched along with Benign Monoclonal Gammopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, Z; Brozova, L; Koukalova, R; Kral, Z; Krejci, M; Mayer, J; Pour, L; Rehak, Z; Sandecka, V; Sevcikova, S; Stork, M | 1 |
| Adam, T; Bacovsky, J; Bartkova, M; Gronowitz, SJ; Minarik, J; Myslivecek, M; Petrova, P; Pika, T; Scudla, V; Zapletalova, J | 1 |
| Dammacco, F; Ferrari, C; Racanelli, V; Rubini, G; Vacca, A | 1 |
| Bhutani, M; Calvo, KR; Carpenter, A; Choyke, PL; Korde, N; Kurdziel, K; Kwok, M; Lamping, E; Landgren, O; Lindenberg, L; Mailankody, S; Manasanch, EE; Maric, I; Mena, E; Minter, AR; Mulquin, M; Roschewski, M; Tageja, N; Tan, E; Turkbey, B; Usmani, SZ; Weiss, BM | 1 |
| Bailly, C; Bodet-Milin, C; Bourgeois, M; Carlier, T; Chérel, M; Guérard, F; Jamet, B; Kraeber-Bodéré, F; Leforestier, R; Moreau, P; Touzeau, C | 1 |
| Bacovský, J; Buriánková, E; Formánek, R; Koranda, P; Minarík, J; Myslivecek, M; Scudla, V; Zapletalová, J | 1 |
| Abe, S; Hatakeyama, N; Hino, H; Hosokawa, E; Inayama, M; Iwahara, Y; Machida, H; Naruse, K; Ogushi, F; Okano, Y; Shinohara, T; Yoshida, M | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
Topics: Bone Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2017 |
5 other study(ies) available for fluorodeoxyglucose f18 and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Prohibitins; Radioimmunoassay; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed | 2015 |
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Precancerous Conditions | 2016 |
[18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2010 |
Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement.
Topics: Aged; Bone Marrow; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin D; Magnetic Resonance Imaging; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |